Sector Chart Satellos Bioscience Inc.

Stocks

MSCL

CA80401L8033

Biotechnology & Medical Research

Delayed Toronto S.E. 10:46:33 2026-08-31 EDT			5-day change	1st Jan Change
12.21 ^CAD	+0.83%		-8.13%	+54.17%

08-13	Satellos Bioscience Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-08	Satellos Bioscience Inc. Reports Six-Month Interim Trailhead Data for Sat-3247 in Adults with Duchenne Muscular Dystrophy	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Bio Therapeutic Drugs

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
SATELLOS BIOSCIENCE INC.	185M	-	-	-	-	-
WUXI APPTEC CO., LTD.	69.54B
ARGENX SE	64.97B
WUXI BIOLOGICS (CAYMAN) INC.	26.51B
INSMED INCORPORATED	25.89B					-
BIONTECH SE	25.64B					-